ATE474595T1 - B. pertussis antigene und ihre verwendung bei der vakzinierung - Google Patents

B. pertussis antigene und ihre verwendung bei der vakzinierung

Info

Publication number
ATE474595T1
ATE474595T1 AT04765806T AT04765806T ATE474595T1 AT E474595 T1 ATE474595 T1 AT E474595T1 AT 04765806 T AT04765806 T AT 04765806T AT 04765806 T AT04765806 T AT 04765806T AT E474595 T1 ATE474595 T1 AT E474595T1
Authority
AT
Austria
Prior art keywords
polypeptides
basb232
antigen
vaccination
categories
Prior art date
Application number
AT04765806T
Other languages
English (en)
Inventor
Cindy Castado
Philippe Denoel
Fabrice Godfroid
Jan Poolman
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0323113A external-priority patent/GB0323113D0/en
Priority claimed from GB0323112A external-priority patent/GB0323112D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE474595T1 publication Critical patent/ATE474595T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04765806T 2003-10-02 2004-10-01 B. pertussis antigene und ihre verwendung bei der vakzinierung ATE474595T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0323113A GB0323113D0 (en) 2003-10-02 2003-10-02 Immunogenic composition
GB0323112A GB0323112D0 (en) 2003-10-02 2003-10-02 Novel compounds
PCT/EP2004/011082 WO2005032584A2 (en) 2003-10-02 2004-10-01 Pertussis antigens and use thereof in vaccination

Publications (1)

Publication Number Publication Date
ATE474595T1 true ATE474595T1 (de) 2010-08-15

Family

ID=34424892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04765806T ATE474595T1 (de) 2003-10-02 2004-10-01 B. pertussis antigene und ihre verwendung bei der vakzinierung

Country Status (8)

Country Link
US (1) US8574596B2 (de)
EP (1) EP1667712B1 (de)
AT (1) ATE474595T1 (de)
AU (1) AU2004277342B2 (de)
CA (1) CA2539715C (de)
DE (1) DE602004028262D1 (de)
ES (1) ES2346314T3 (de)
WO (1) WO2005032584A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020059A2 (en) * 2000-09-01 2002-03-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
US9486515B2 (en) 2005-06-27 2016-11-08 Glaxosmithkline Biologicals S.A. Immunogenic composition
WO2009094006A2 (en) 2007-10-25 2009-07-30 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
CU23679A1 (es) * 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
EP2430040A1 (de) * 2009-05-11 2012-03-21 Novartis AG Antigenaufreinigungs­verfahren für pertactinantigen
WO2010135704A2 (en) * 2009-05-22 2010-11-25 Institute For Systems Biology Secretion-related bacterial proteins for nlrc4 stimulation
WO2012041899A1 (en) * 2010-09-28 2012-04-05 Xbrane Bioscience Ab Fusion protein for secretory protein expression
WO2012104821A1 (en) * 2011-02-04 2012-08-09 Pfizer Inc. Immunogenic bordetella bronchiseptica compositions
WO2014024026A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against rsv and b. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
JP6198298B2 (ja) * 2013-04-02 2017-09-20 国立感染症研究所長 百日咳の血清診断方法
KR20160040290A (ko) * 2013-08-05 2016-04-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 조합 면역원성 조성물
EP2921178A1 (de) * 2014-03-19 2015-09-23 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin Toll-like-Rezeptor-2-Agonisten und Impfstoffe und Verwendungen davon
WO2016011155A1 (en) * 2014-07-15 2016-01-21 Kapre Subhash V Genetically detoxified pertussis that maintains intrinsic adjuvant activity
EP3283102A4 (de) * 2015-04-16 2018-10-03 Inventprise, LLC. Immunogene impfstoffzusammensetzungen gegen bordetella pertussis
US10799573B2 (en) * 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
KR101816081B1 (ko) * 2016-06-03 2018-01-08 연세대학교 산학협력단 백일해균 유래 LysRS를 포함하는 항원 단백질 및 이를 이용한 백일해 진단 방법
KR102426041B1 (ko) * 2017-08-01 2022-07-29 주식회사 녹십자 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법
US11851479B2 (en) 2018-06-18 2023-12-26 Dxdiscovery, Inc. Methods and compositions for pertussis diagnosis
CN112912097A (zh) * 2018-08-23 2021-06-04 葛兰素史密丝克莱恩生物有限公司 免疫原性蛋白和组合物
US11701417B2 (en) 2019-03-27 2023-07-18 West Virginia University Vaccine formulation to protect against pertussis
US20250263447A1 (en) * 2020-09-04 2025-08-21 Intravacc B.V. Ompa mutations enhance omv production in bordetella pertussis
CN113354742A (zh) * 2021-05-10 2021-09-07 重庆市畜牧科学院 一种布鲁氏杆菌基因工程亚单位疫苗及其制备方法和应用
CN118388664B (zh) * 2024-05-21 2024-12-03 广东省农业科学院动物卫生研究所 副猪嗜血杆菌融合抗原及其应用
CN118853525B (zh) * 2024-09-26 2025-01-07 上海羽冠生物技术有限公司 经修饰的百日咳鲍特菌菌株
CN120118819B (zh) * 2025-05-15 2025-08-12 上海羽冠生物技术有限公司 一种经修饰的百日咳鲍特菌菌株及其应用

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB222021A (en) 1924-01-24 1924-09-25 Berkel & Parnall Mach Mfg Co Improvements in machines for slicing meat and other substances
EP0027888B1 (de) 1979-09-21 1986-04-16 Hitachi, Ltd. Halbleiterschalter
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4709017A (en) 1985-06-07 1987-11-24 President And Fellows Of Harvard College Modified toxic vaccines
IT1187753B (it) 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4950740A (en) 1987-03-17 1990-08-21 Cetus Corporation Recombinant diphtheria vaccines
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
DE68929323T2 (de) 1988-12-16 2002-04-18 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Pneumolysin-mutanten und pneumokokken-impfstoffe daraus
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
CA2087160A1 (en) 1990-07-16 1992-01-17 P. Frederick Sparling Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
ATE253114T1 (de) 1990-08-23 2003-11-15 Univ North Carolina Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis
US5912336A (en) 1990-08-23 1999-06-15 University Of North Carolina At Chapel Hill Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
US6592876B1 (en) 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
FR2682041B1 (fr) 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
WO1993015760A1 (en) 1992-02-11 1993-08-19 U.S. Government, As Represented By The Secretary Of The Army Dual carrier immunogenic construct
ES2130265T3 (es) 1992-05-06 1999-07-01 Harvard College Region de union al receptor de la toxina difterica.
FR2692592B1 (fr) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
NZ253137A (en) 1992-06-25 1996-08-27 Smithkline Beecham Biolog Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.
EP0689454B2 (de) 1993-03-23 2005-02-23 SMITHKLINE BEECHAM BIOLOGICALS s.a. 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
EP0693084A4 (de) 1993-04-06 1999-06-02 Hutchinson Fred Cancer Res Chimäre cytokinrezeptoren in lymphozyten
DK0699076T3 (da) 1993-05-18 2003-03-03 Univ Ohio State Res Found Vaccine mod mellemørebetændelse
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5917017A (en) 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
DE69535905D1 (de) 1994-07-15 2009-02-26 Coley Pharm Group Inc Immunomodulatorische Oligonukleotide
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US5843464A (en) 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
JPH11507214A (ja) 1995-06-07 1999-06-29 バイオケム ヴァシーンズ インク． Ｈｓｐ７０ファミリーに属する連鎖球菌の熱ショック蛋白質メンバー
IL122588A (en) * 1995-06-23 2001-12-23 Smithkline Beecham Biolog A combination vaccine containing a polysaccharide conjugated antigen attached to a phosphate aluminum and one or more additional antibodies
EP0912608B1 (de) 1996-05-01 2006-04-19 The Rockefeller University Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
US5882896A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5882871A (en) 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
PT942983E (pt) 1996-10-31 2007-02-28 Human Genome Sciences Inc Antigénios e vacinas de streptococcus pneumoniae
EP0998557A2 (de) 1997-07-21 2000-05-10 North American Vaccine, Inc. Modifizierte immunogene pneumolysin, deren zusammensetzungen und deren verwendungen als impfung
AU744733B2 (en) 1997-08-15 2002-02-28 Technology Foundation (Technologiestichting Stw) Neisseria lactoferrin binding protein
GB9717953D0 (en) 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
US6503511B1 (en) 1998-04-07 2003-01-07 Medimmune, Inc. Derivatives of choline binding proteins for vaccines
GB9808866D0 (en) 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
WO2001055309A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
US7285289B2 (en) * 2002-04-12 2007-10-23 Nagy Jon O Nanoparticle vaccines
US9473463B2 (en) 2014-07-29 2016-10-18 Combined Conditional Access Development & Support, LLC Control word and associated entitlement control message caching and reuse

Also Published As

Publication number Publication date
CA2539715A1 (en) 2005-04-14
WO2005032584A3 (en) 2005-11-10
DE602004028262D1 (de) 2010-09-02
AU2004277342B2 (en) 2010-12-16
EP1667712A2 (de) 2006-06-14
US8574596B2 (en) 2013-11-05
AU2004277342A1 (en) 2005-04-14
CA2539715C (en) 2015-02-24
EP1667712B1 (de) 2010-07-21
WO2005032584A2 (en) 2005-04-14
US20070116711A1 (en) 2007-05-24
ES2346314T3 (es) 2010-10-14

Similar Documents

Publication Publication Date Title
ATE474595T1 (de) B. pertussis antigene und ihre verwendung bei der vakzinierung
IS7601A (is) Neisser-bóluefnasamsetningar sem innihalda blönduaf mótefnavökvum
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2002081646A3 (en) Epitope sequences
ATE524194T1 (de) Antigene polypeptide
ATE461938T1 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
DK1078063T3 (da) BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis
NO20005952L (no) Antigene polypeptider fra Neisseria Meningitidis, tilsvarende polynukleotider og beskyttende antistoffer
DK1163343T3 (da) Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer
DE69918446D1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
ATE354657T1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
DK1082435T3 (da) Proteiner og gener fra Moraxella catarrhalis, antigener, antistoffer og anvendelser
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
DE69827800D1 (de) Epitope des shigella-artigen toxins und ihre verwendung als impfstoff und in der diagnose
WO2002066503A3 (en) H. influenzae antigen basb213
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE293692T1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties